Pyxis Diagnostics Israeli Company
Pyxis Diagnostics is developing an AI-powered cancer diagnostics platform for predicting immuno-oncology (IO) drug response. The company's platform can predict IO drug response for many cancer types. It can also suggest alternative treatment routes in cases when the predicted drug response is low, improving the quality of life of oncological patients.
Health Tech & Life Sciences
Biotechnology
Health Care
Medical
Alternatives
No alternatives listed yet.
AI-Generated Alternatives
Powered by AI May contain mistakes
AI is thinking and generating alternatives...
{
$el.querySelectorAll('a').forEach(link => {
link.target = '_blank';
link.rel = 'noopener noreferrer';
});
})"
class="ai-alternatives-content prose prose-sm dark:prose-invert prose-headings:text-gray-900 dark:prose-headings:text-gray-100 prose-p:text-gray-700 dark:prose-p:text-gray-300 prose-strong:text-gray-900 dark:prose-strong:text-gray-100 max-w-none [&>h2]:mb-4 [&>h2]:mt-8 [&>h3]:mb-3 [&>h3]:mt-6 [&>p]:mb-4 [&>ul>li]:my-2 [&>ul]:space-y-3"
>
Suggest an Alternative
Office Locations
Jerusalem, Israel
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/pyxis-diagnostics
[2]
crunchbase.com
- https://www.crunchbase.com/organization/pyxis-diagnostics
External links are provided for reference and verification purposes.